← Leaderboards
Mitchell Allen Avery
Averta Pharmaceuticals, Llc
$401,250
Attributed
$401,250
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$401,250 · 1
By mechanism
R42$401,250 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “2,4-Thiazolidinedione”
- Walter N Kernan · Yale University$11,636,848
- Steven E Kahn · Va Puget Sound Healthcare System$5,167,747
- Mitchell A. Lazar · University Of Pennsylvania$4,385,685
- Yuqing E Chen · University Of Michigan At Ann Arbor$4,176,715
- W Timothy Garvey · Medical University Of South Carolina$3,850,601
- Kieren J Mather · Indiana Univ-Purdue Univ At Indianapolis$3,211,957
Research focus
2,4-ThiazolidinedioneAdverse EffectsAffectAgreementAnimal ModelArtsCell TypeClassClinical Trials, Phase IClinical Trials, Phase IiDesignDoseDrugs, InvestigationalEpidermisEvaluationFinancial SupportHyperplasiaInflammatoryInterestKeratinocyteNovel TherapeuticsPathway InteractionsPharmaceutical PreparationsPharmacologic Substance